Leu-Pro-Phe-Phe-Asp

Leu-Pro-Phe-Phe-Asp, also known as LPFFD, is a synthetic pentapeptide composed of the amino acids leucine, proline, phenylalanine, phenylalanine, and aspartic acid. This sequence has drawn considerable attention in the scientific community due to its unique structural properties and its role in modulating protein-protein interactions, particularly those implicated in neurodegenerative processes. As a research reagent, LPFFD is valued for its stability, solubility in aqueous solutions, and ease of integration into various experimental protocols. Its structure enables it to interact with specific peptide sequences, making it a useful tool for probing molecular mechanisms underlying aggregation phenomena. Researchers appreciate its versatility, as it can be incorporated into in vitro assays, cell culture studies, and biochemical analyses, facilitating a broad spectrum of investigative applications across neuroscience, biochemistry, and molecular biology disciplines.

Neurodegenerative Disease Research: LPFFD is extensively utilized in the study of amyloid-beta aggregation, a hallmark of Alzheimer's disease and related neurodegenerative disorders. By binding to specific sequences within amyloidogenic peptides, it can modulate their propensity to form toxic aggregates, thereby serving as a model inhibitor in aggregation assays. Scientists leverage this property to dissect the molecular mechanisms of amyloid formation, screen for potential aggregation inhibitors, and develop novel therapeutic strategies targeting protein misfolding. Its application in these studies provides insights into the pathophysiology of neurodegeneration and aids in the identification of new molecular targets for intervention.

Protein-Protein Interaction Studies: The pentapeptide is often employed as a molecular probe to investigate the dynamics of protein-protein interactions. Its defined sequence allows researchers to study the specificity and affinity of binding events between peptides and larger protein complexes. By introducing LPFFD into binding assays, scientists can map interaction domains, evaluate the effects of sequence modifications, and elucidate the structural determinants governing protein association. This approach contributes to a deeper understanding of cellular signaling pathways and the regulatory mechanisms that control protein function in health and disease.

Peptide-Based Drug Discovery: LPFFD serves as a valuable scaffold in the development of peptide-based drug candidates. Its stability and bioactive conformation make it an attractive lead compound for the design of analogs with enhanced pharmacological properties. Medicinal chemists utilize this peptide to generate libraries of derivatives, which are then screened for improved efficacy, selectivity, and metabolic stability. Through structure-activity relationship studies, researchers can optimize peptide sequences to target specific molecular pathways, facilitating the rational design of next-generation therapeutics for a range of indications.

Biophysical and Structural Analysis: The well-defined structure of LPFFD makes it an ideal subject for biophysical characterization using techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD), and X-ray crystallography. These studies provide detailed information on its conformational preferences, secondary structure elements, and interaction surfaces. By analyzing how the peptide behaves in different environments, scientists gain valuable data on peptide folding, aggregation kinetics, and the influence of sequence modifications. Such insights are instrumental in guiding the design of more effective peptide-based tools and therapeutics.

Molecular Modeling and Computational Studies: LPFFD is frequently incorporated into molecular modeling and simulation studies aimed at predicting peptide behavior, interaction energies, and binding modes. Computational chemists use it as a reference sequence to validate algorithms, benchmark docking protocols, and explore the energetics of peptide-protein interactions. These in silico approaches complement experimental findings, providing a comprehensive understanding of the factors influencing peptide activity and stability. The integration of computational and experimental data accelerates the discovery and optimization of functional peptides for research and therapeutic applications.

In summary, Leu-Pro-Phe-Phe-Asp stands out as a multifaceted research tool with significant utility across diverse scientific domains. Its application in neurodegenerative disease research, protein-protein interaction studies, peptide-based drug discovery, biophysical and structural analysis, and molecular modeling underscores its value in advancing our understanding of complex biological processes. The peptide's versatility and well-characterized properties make it a preferred choice for researchers seeking to unravel the molecular underpinnings of disease, develop innovative therapeutic strategies, and explore the frontiers of peptide science.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

4. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency